Ofatumumab, a fully human anti-CD20 monoclonal antibody, is a disease-modifying therapy (DMT) approved for the treatment of ...

The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...

The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...

These fixes and upgrades can make such a noticeable difference, you'll be amazed you didn't have to call a professional.